03.21.23 -- Expediting A Promising New Therapy With Softgel Technology

This webinar demonstrates how additional screening strategies can help predict a molecule’s future success. Experts share a case study that illustrates how to use PBPK modeling, the developability classification system, and the biopharmaceutics drug distribution classification system together to facilitate the development of a molecule.

Oral dosage forms have remained a cornerstone of drug development, despite the proliferation of alternative dosage forms to address unmet medical needs. To better understand the landscape today, 200+ people involved in the oral dose market shared their views on barriers to the development of oral formulations and technological responses to them.

A biotech company exploring novel therapeutics for neuroscience indications developed a promising new chemical entity for the treatment of a severe pediatric genetic disease yet drug delivery challenges threatened the realization of their Fast Track status designation. Softgel technology helped to overcome potential hurdles and expedite the Phase II/III clinical trial.